4//SEC Filing
Griffin Stephen D. 4
Accession 0001171843-24-003314
CIK 0000898437other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:10 PM ET
Size
8.0 KB
Accession
0001171843-24-003314
Insider Transaction Report
Form 4
Griffin Stephen D.
EVP, CFO & COO
Transactions
- Award
Stock Option (Right to Buy)
2024-06-03+96,525→ 96,525 totalExercise: $29.35Exp: 2034-06-03→ Common Stock (96,525 underlying) - Award
Restricted Stock Unit
2024-06-03+38,520→ 38,520 totalExercise: $0.00→ Common Stock (38,520 underlying)
Footnotes (3)
- [F1]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025.
- [F2]Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
- [F3]The premium priced stock options vest in three equal annual installments beginning on June 3, 2025.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001831125
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:10 PM ET
- Size
- 8.0 KB